Supervisory Board Member

Dr. Norbert W. Bischofberger

bischofbergerMember of the Supervisory Board effective April 2017, elected until 2022

President and Chief Executive Officer at Kronos Bio, Inc.

 

 

Membership of comparable control bodies of corporations in Germany or abroad:

 

  • Kronos Bio, Inc. (Board of Directors)
  • Morphic Therapeutic, Inc. (Board of Directors)**

 

** listed company
 

Curriculum Vitae

January 10, 1956 born in Mellau, Austria
1975–1980 Studies of chemistry at Leopold-Franzens-University, Innsbruck, Austria
1980-1983 Doctorate (Dr. rer. nat.) at the Eidgenössische Technische Hochschule Zurich, Switzerland
1983–1984 Postdoc at Syntex, Inc., Palo Alto, California, USA
1984–1986 Postdoc at Harvard University, Cambridge, Massachusetts, USA
1986–1990 Scientist in the Molecular Biology Department at Genentech Inc., South San Francisco, California, USA, from 1988 Manager DNA Synthesis
since 1990 Gilead Sciences Inc., Foster City, California, USA
1990 –1993 Director Organic Chemistry
1993–1995 Vice President Organic Chemistry
1995–1997 Vice President Research
1997–1999 Senior Vice President Research
1999–2007 Senior Vice President Research and Development
2007–2018 Executive Vice President Research & Development and Chief Scientific Officer
since 2018 President and Chief Executive Officer at Kronos Bio, Inc.